Quinn Opportunity Partners LLC
Position in NKTR — Nektar Therapeutics
CIK 1633275
CHARLOTTESVILLE, VA
Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,686,235
-$2,210,586 QoQ
Shares Held
153,076
-14.6% QoQ
Ownership
0.448%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#44
of 240 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quinn Opportunity Partners LLC holds $47,802,755 across 24 Biotechnology names. NKTR ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
153,832 | $14,314,067 | |
| 2 | NKTR |
Nektar Therapeutics
This page
|
153,076 | $10,686,235 | |
| 3 | ABVX |
Abivax S.A.
|
66,045 | $8,801,156 | |
| 4 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
265,070 | $1,654,036 | |
| 5 | XNCR |
Xencor Inc
|
90,000 | $1,449,000 | |
| 6 | SPRB |
Spruce Biosciences, Inc.
|
26,810 | $1,447,740 | |
| 7 | SPRY |
ARS Pharmaceuticals, Inc.
|
175,000 | $1,401,750 | |
| 8 | ABUS |
Arbutus Biopharma Corp
|
255,214 | $1,225,027 |
All Filings in NKTR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,686,235 | 153,076 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,896,821 | 179,247 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,630,499 | 85,868 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,251,489 | 109,868 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||